Chemoinformaics analysis of 1,5,9-trimethyl-12-(1-methylethyl)
| Molecular Weight | 306.49 | nRot | 1 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 14 |
| Exact Molecular Weight | 306.256 | nRing | 1 |
| Solubility: LogS | -3.367 | nHRing | 0 |
| Solubility: LogP | 5.27 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.675 |
| nHD | 2 | BPOL | 34.109 |
| QED | 0.684 |
| Synth | 4.605 |
| Natural Product Likeliness | 3.328 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.012 |
| HIA | 0.01 |
| CACO-2 | -4.336 |
| MDCK | 0.0000194 |
| BBB | 0.377 |
| PPB | 0.974349 |
| VDSS | 1.432 |
| FU | 0.0307615 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.338 |
| CYP2c19-inh | 0.321 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.504 |
| CYP2c9-sub | 0.827 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.056 |
| CYP3a4-inh | 0.876 |
| CYP3a4-sub | 0.542 |
| CL | 7.845 |
| T12 | 0.143 |
| hERG | 0.012 |
| Ames | 0.009 |
| ROA | 0.014 |
| SkinSen | 0.032 |
| Carcinogencity | 0.528 |
| EI | 0.085 |
| Respiratory | 0.005 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.530084 |